Journal of Oncology / 2010 / Article / Fig 2

Review Article

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer

Figure 2

Kaplan Meier Analysis of overall survival before starting a new line of therapy for patients with metastatic breast cancer (a), metastatic colorectal cancer (b), and castration resistant prostate cancer (c). Patients were divided into those with Favorable and Unfavorable CTC. The cutoff value between favorable and unfavorable CTC was 5 CTC/7.5 mL blood for breast and prostate cancer and 3 CTC/7.5 mL blood for prostate cancer.